They can reduce the risks of myocardial infarction, stroke, kidney disease, chronic joint pain all this can also reduce costs in our precious Medicare program. Heres what to know about the Medicare GLP-1 Bridge, according to the programs website: Which GLP-1 Drugs Are Covered
References Alba M, Fintini D, Sagazio A, Lawrence B, Castaigne JP, Frohman LA, Salvatori R
They are thought to have anti-inflammatory properties and an other effect, which makes many doctors hesitant to wean patients off
Patients that maintained treatment response at Week 3 of the open label treatment phase (N=116) were eligible to be randomized to ongoing treatment with the same dose of VYVANSE (N=56) or switched to placebo (N=60) during the double-blind phase
GLP-1 helps to control appetite and make you feel full after eating